SIRT1 is known to be susceptible to intracellular fluctuations in the NAD+/NADH ratio and may influence type 2 diabetes risk through its known epigenetic effects and β-cell apoptosis [115,116]. The gene discussed is SIRT1; the disease is type 2 diabetes mellitus.